-+ 0.00%
-+ 0.00%
-+ 0.00%

bioAffinity closes private placement of warrants for 980,072 shares at $6.122 exercise price

PUBT·10/09/2026 15:37:30
Listen to the news
bioAffinity closes private placement of warrants for 980,072 shares at $6.122 exercise price
  • bioAffinity Technologies closed a $4 million registered direct financing priced at $6.122 per share, including pre-funded warrants at $6.115.
  • Concurrent private placement closed for warrants covering 980,072 shares at a $6.122 exercise price, subject to stockholder approval.
  • Pre-funded warrants carry a $0.007 exercise price; private placement warrants expire five years after stockholder approval.
  • Net proceeds earmarked for working capital, supporting expected CyPath Lung sales growth, general corporate purposes.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. bioAffinity Technologies Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20261009218447) on October 09, 2026, and is solely responsible for the information contained therein.